Truberzi, also known as
This drug works by binding to certain receptors in the digestive system, to slow down the movement of food through the gut. This helps to relieve associated stomach cramps and the urgency for a person to go to the toilet.
Professor Carole Longson, director of the
“Truberzi addresses multiple symptoms of IBS-D and works in a different way compared to existing treatments, and we are pleased to be able to recommend it as an additional option for treating IBS-D.”
NICE has recommended Truberzi for patients with IBS-D to be offered only in secondary care and as long as it's stopped after 4 weeks if the treatment is not working.
It is estimated that between 10-20% of the UK general population has IBS, and of